Morgan Stanley
- SEC CIK
- 0000895421
- Latest filing
- Aug 13, 2026
JSPR holding history
Jasper Therapeutics, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
JSPR overviewAll 13F holders of JSPRFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,724
- Value
- $726
- % of portfolio
- <0.1%
- Quarters held
- 20
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,724 | $726 | <0.1% | −1,331,696−99.9% | Reduced | Holders |
| Q1 2026 | 1,333,420 | $1.17M | <0.1% | −636,365−32.3% | Reduced | Holders |
| Q4 2025 | 1,969,785 | $3.60M | <0.1% | +1,179,825+149.4% | Added | Holders |
| Q3 2025 | 789,960 | $1.88M | <0.1% | +20,210+2.6% | Added | Holders |
| Q2 2025 | 769,750 | $4.27M | <0.1% | +115,766+17.7% | Added | Holders |
| Q1 2025 | 653,984 | $2.81M | <0.1% | +49,192+8.1% | Added | Holders |
| Q4 2024 | 604,792 | $12.9M | <0.1% | +39,070+6.9% | Added | Holders |
| Q3 2024 | 565,722 | $10.6M | <0.1% | +256,303+82.8% | Added | Holders |
| Q2 2024 | 309,419 | $7.02M | <0.1% | +133,002+75.4% | Added | Holders |
| Q1 2024 | 176,417 | $5.18M | <0.1% | −1,523,133−89.6% | Reduced | Holders |
| Q4 2023 | 1,699,550 | $1.34M | <0.1% | +918,671+117.6% | Added | Holders |
| Q3 2023 | 780,879 | $546.6K | <0.1% | +459,329+142.8% | Added | Holders |
| Q2 2023 | 321,550 | $440.5K | <0.1% | −56,522−15.0% | Reduced | Holders |
| Q1 2023 | 378,072 | $684.3K | <0.1% | +375,022+12,295.8% | Added | Holders |
| Q4 2022 | 3,050 | $1.47K | <0.1% | −75−2.4% | Reduced | Holders |
| Q3 2022 | 3,125 | $2.00K | <0.1% | +125+4.2% | Added | Holders |
| Q2 2022 | 3,000 | $6.00K | <0.1% | −1,276−29.8% | Reduced | Holders |
| Q1 2022 | 4,276 | $15.0K | <0.1% | −294,513−98.6% | Reduced | Holders |
| Q4 2021 | 298,789 | $2.35M | <0.1% | +189,929+174.5% | Added | Holders |
| Q3 2021 | 108,860 | $1.12M | <0.1% | +108,860 | New | Holders |